Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.
Journal Article (Journal Article)
AIM: To describe the exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. An institutional review board-approved protocol for a clopidogrel pharmacogenetic program in a community pharmacy was developed to address feasibility and evaluate the pilot program. STUDY CONCEPT: Subjects taking clopidogrel are asked to participate at the point of medication dispensing. A pharmacist schedules an appointment with subjects to discuss the study and collects a buccal swab sample for CYP2C19 testing. When the results are available, the pharmacist consults with the subject's prescriber regarding test result interpretation and associated recommendations, and schedules a second appointment with the participant to discuss results and review any physician-approved therapeutic changes. The intervention-associated consultation is then billed to the subject's insurance. RESULTS: Subject enrollment has begun. CONCLUSION: Community pharmacists may be valuable partners in pharmacogenetics.
Full Text
Duke Authors
Cited Authors
- O'Connor, SK; Ferreri, SP; Michaels, NM; Greco, AJ; Viera, AJ; Faruki, H; McLeod, HL; Roederer, MW
Published Date
- June 2012
Published In
Volume / Issue
- 13 / 8
Start / End Page
- 955 - 962
PubMed ID
- 22676199
Electronic International Standard Serial Number (EISSN)
- 1744-8042
Digital Object Identifier (DOI)
- 10.2217/pgs.12.67
Language
- eng
Conference Location
- England